Literature DB >> 6378916

The treatment of infected and uninfected non-union.

R M Lifeso, F Al-Saati.   

Abstract

One hundred and sixteen patients with 129 ununited fractures were treated either by rigid internal fixation and bone grafting or, in 14 tibial non-unions, by posterolateral bone grafting. In 37 actively infected cases this was combined with sequestrectomy and appropriate antibiotics. The final success rate was 98.4%. Technical errors or inadequate immobilisation after operation in patients with severe osteoporosis led to some early failures. No patient had a discharge or evidence of osteomyelitis after removal of metal. Rigid internal fixation with or without bone grafting is the treatment of choice for established non-union with bone loss when true synovial pseudarthrosis is present, when malalignment or shortening needs correction, and when prolonged immobilisation is either difficult or would lead to unacceptable stiffness in adjacent joints. Active osteomyelitis is not a contra-indication to internal fixation.

Entities:  

Mesh:

Year:  1984        PMID: 6378916

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

Review 1.  Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature review.

Authors:  Louis-Romée Le Nail; Julien Stanovici; Joseph Fournier; Marie Splingard; Jorge Domenech; Philippe Rosset
Journal:  Int Orthop       Date:  2014-04-13       Impact factor: 3.075

2.  Antibody response to Staphylococcus aureus surface proteins in rabbits with persistent osteomyelitis after treatment with demineralized bone implants.

Authors:  V L Thomas; B A Sanford; B S Keogh; R G Triplett
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Gap nonunion of tibia treated by Huntington's procedure.

Authors:  Zile S Kundu; Vinay Gupta; Sukhbir S Sangwan; Pardeep Kamboj
Journal:  Indian J Orthop       Date:  2012-11       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.